Cochrane Abstracts
Hydroxyurea (hydroxycarbamide) for sickle cell disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Hydroxyurea (hydroxycarbamide) for Sickle Cell Disease." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433445/all/Hydroxyurea__hydroxycarbamide__for_sickle_cell_disease.
Hydroxyurea (hydroxycarbamide) for sickle cell disease. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433445/all/Hydroxyurea__hydroxycarbamide__for_sickle_cell_disease. Accessed January 31, 2025.
Hydroxyurea (hydroxycarbamide) for sickle cell disease. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433445/all/Hydroxyurea__hydroxycarbamide__for_sickle_cell_disease
Hydroxyurea (hydroxycarbamide) for Sickle Cell Disease [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 31]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433445/all/Hydroxyurea__hydroxycarbamide__for_sickle_cell_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Hydroxyurea (hydroxycarbamide) for sickle cell disease
ID - 433445
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433445/all/Hydroxyurea__hydroxycarbamide__for_sickle_cell_disease
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
